MoonLake Immunotherapeutics SEC filings MLTX
MoonLake Immunotherapeutics has 331 filings in SEC EDGAR's recent list, going back to Aug 28, 2020. Its latest annual report, Form ARS, was filed on Apr 21, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Nov 4, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Nov 4, 2026 (results of operations). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| S-8 | Employee stock plan registration | Aug 10, 2026 | — |
| S-3ASR | Automatic shelf registration | Aug 10, 2026 | — |
| 424B5 | Prospectus supplement | Jun 24, 2026 | — |
| 424B5 | Prospectus supplement | Jun 22, 2026 | — |
| 424B5 | Prospectus supplement | Nov 5, 2025 | — |
| S-3 | Shelf registration | Aug 31, 2023 | — |
| 424B5 | Prospectus supplement | Jun 29, 2023 | — |
| 424B3 | Prospectus | Jun 27, 2023 | — |
| 424B5 | Prospectus supplement | Jun 26, 2023 | — |
| 424B5 | Prospectus supplement | May 11, 2023 | — |
| S-3 | Shelf registration | May 1, 2023 | — |
| POS AM | Filing | May 1, 2023 | — |
| 424B3 | Prospectus | Mar 28, 2023 | — |
| POS AM | Filing | Mar 20, 2023 | — |
| 424B3 | Prospectus | Nov 14, 2022 | — |
| S-8 | Employee stock plan registration | Sep 30, 2022 | — |
| 424B3 | Prospectus | Aug 12, 2022 | — |
| 424B3 | Prospectus | Aug 2, 2022 | — |
| S-1/A | Amended registration statement | Jul 26, 2022 | — |
| S-1/A | Amended registration statement | Jul 15, 2022 | — |
| S-1/A | Amended registration statement | May 2, 2022 | — |
| S-1/A | Amended registration statement | Mar 14, 2022 | — |
| S-1/A | Amended registration statement | Mar 8, 2022 | — |
| S-1 | Registration statement | Feb 11, 2022 | — |
| 424B4 | Prospectus | Oct 21, 2020 | — |
| S-1/A | Amended registration statement | Oct 16, 2020 | — |
| S-1/A | Amended registration statement | Oct 14, 2020 | — |
| S-1 | Registration statement | Oct 1, 2020 | — |
Showing 28 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- MLTX (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- Cayman Islands
- Headquarters
- Zug, Switzerland
- SEC filer status
- Large accelerated filer
- SEC CIK
- 1821586
- Former names
- Helix Acquisition Corp (until Mar 31, 2022)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.